AXQ Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.21M Buy
28,303
+14,816
+110% +$1.2M 0.24% 127
2026
Q1
$1.17M Buy
+13,487
New +$1.29M 0.15% 211
2025
Q3
Sell
-9,890
Closed -$862K 731
2025
Q2
$862K Buy
9,890
+2,013
+26% +$171K 0.28% 110
2025
Q1
$708K Buy
7,877
+2,519
+47% +$225K 0.28% 114
2024
Q4
$428K Buy
5,358
+1,340
+33% +$116K 0.19% 199
2024
Q3
$362K Buy
+4,018
New +$338K 0.11% 313
2024
Q2
Sell
-25,500
Closed -$2.22M 614
2024
Q1
$2.22M Buy
+25,500
New +$2.18M 0.53% 16
2023
Q4
Sell
-3,600
Closed -$282K 751
2023
Q3
$282K Sell
3,600
-2,800
-44% -$234K 0.1% 327
2023
Q2
$564K Buy
+6,400
New +$551K 0.7% 19
2023
Q1
Sell
-8,667
Closed -$674K 574
2022
Q4
$674K Buy
+8,667
New +$702K 0.47% 67

Other funds holding MDT

AXQ Capital's MDT Position: Q2 2026 in Review

AXQ Capital increased its Medtronic (MDT) stake by 110% in Q2 2026, buying an estimated $1.2M and bringing the position to 28,303 shares worth $2.21M. The position accounts for 0.24% of the portfolio, ranked #127.

AXQ Capital first reported a position in MDT in Q4 2022 and has held it in 10 quarters since. The position peaked at $2.22M in Q1 2024. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • AXQ Capital held 28,303 shares of Medtronic worth $2.21M as of Q2 2026.
  • AXQ Capital bought 14,816 Medtronic shares in Q2 2026, an estimated $1.2M.
  • Medtronic made up 0.24% of AXQ Capital's portfolio in Q2 2026, its #127 holding.
  • AXQ Capital first reported a position in Medtronic in Q4 2022 and has held it in 10 quarters since.
  • AXQ Capital's Medtronic position peaked at $2.22M in Q1 2024.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.